SARC038: A Phase 2 Study of Regorafenib in Combination with Nivolumab in Patients with Refractory orRecurrent Osteosarcoma

Project: Research project

Project Details

Description

SARC038: A Phase 2 Study of Regorafenib in Combination with Nivolumab in Patients with Refractory or Recurrent Osteosarcoma
StatusActive
Effective start/end date2/16/2211/30/22

Funding

  • SARC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.